J. Safra Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

J. Safra Asset Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35M	Buy	319,636 +8,835	+3%	+$914K	1.61%	15
2026 Q1	$32.3M	Buy	310,801 +5,329	+2%	+$568K	1.74%	15
2025 Q4	$31.5M	Buy	305,472 +19,685	+7%	+$1.91M	1.65%	16
2025 Q3	$25.8M	Buy	285,787 +12,011	+4%	+$1.05M	1.57%	16
2025 Q2	$24.1M	Buy	273,776 +4,950	+2%	+$429K	1.68%	16
2025 Q1	$24.5M	Buy	268,826 +8,559	+3%	+$771K	1.99%	16
2024 Q4	$22.4M	Buy	260,267 +181,511	+230%	+$16.4M	1.82%	17
2024 Q3	$7.47M	Buy	78,756 +5,147	+7%	+$489K	0.71%	19
2024 Q2	$6.73M	Buy	73,609 +4,084	+6%	+$365K	0.68%	19
2024 Q1	$6.31M	Buy	+69,525	New	+$6.09M	0.71%	18

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

J. Safra Asset Management's PPH Position: Q2 2026 in Review

J. Safra Asset Management increased its VanEck Pharmaceutical ETF (PPH) stake by 2.8% in Q2 2026, buying an estimated $914K and bringing the position to 319,636 shares worth $35M. The position accounts for 1.61% of the portfolio, ranked #15.

J. Safra Asset Management first reported a position in PPH in Q1 2024 and has held it in 10 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

J. Safra Asset Management held 319,636 shares of VanEck Pharmaceutical ETF worth $35M as of Q2 2026.
J. Safra Asset Management bought 8,835 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $914K.
VanEck Pharmaceutical ETF made up 1.61% of J. Safra Asset Management's portfolio in Q2 2026, its #15 holding.
J. Safra Asset Management first reported a position in VanEck Pharmaceutical ETF in Q1 2024 and has held it in 10 quarters since.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.